Lu S F, Herbert B, Haufe G, Laue K W, Padgett W L, Oshunleti O, Daly J W, Kirk K L
Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20893, USA.
J Med Chem. 2000 Apr 20;43(8):1611-9. doi: 10.1021/jm990599h.
Several routes to the enantiomers of fluoronorepinephrines (1) and fluoroepinephrines (2) were explored. A catalytic enantioselective oxazaborolidine reduction and a chiral (salen)Ti(IV) catalyzed asymmetric synthesis of silyl cyanohydrins proved efficacious in the key stereo-defining steps of two respective routes. Binding studies of the catecholamines with alpha(1)-, alpha(2)-, beta(1)-, and beta(2)-adrenergic receptors were examined. The assays confirmed that fluorine substitution had marked effects on the affinity of (R)-norepinephrine and (R)-epinephrine for adrenergic receptors, depending on the position of substitution. Thus, a fluoro substituent at the 2-position of (R)-norepinephrine and (R)-epinephrine reduced activity at both alpha(1)- and alpha(2)-receptors and enhanced activity at beta(1)- and beta(2)-receptors, while fluorination at the 6-position reduced activity at the beta(1)- and beta(2)-receptors. The effects of fluorine substitution on the S-isomers were less predictable.
探索了几种合成氟去甲肾上腺素(1)和氟肾上腺素(2)对映体的路线。催化对映选择性恶唑硼烷还原反应以及手性(salen)Ti(IV)催化的硅氰醇不对称合成反应在两条各自路线的关键立体定向步骤中均证明是有效的。研究了儿茶酚胺与α(1)-、α(2)-、β(1)-和β(2)-肾上腺素能受体的结合情况。这些测定证实,氟取代对(R)-去甲肾上腺素和(R)-肾上腺素与肾上腺素能受体的亲和力有显著影响,这取决于取代位置。因此,(R)-去甲肾上腺素和(R)-肾上腺素2位上的氟取代基降低了α(1)-和α(2)-受体的活性,并增强了β(1)-和β(2)-受体的活性,而6位上的氟化则降低了β(1)-和β((2)-受体的活性。氟取代对S-异构体的影响较难预测。